[A clinical analysis of hypothyroidism in very low birth weight/extremely low birth weight infants].
Journal
Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
ISSN: 1008-8830
Titre abrégé: Zhongguo Dang Dai Er Ke Za Zhi
Pays: China
ID NLM: 100909956
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
entrez:
16
10
2020
pubmed:
17
10
2020
medline:
15
12
2020
Statut:
ppublish
Résumé
To study the risk factors and treatment outcome of hypothyroidism in very low birth weight/extremely low birth weight (VLBW/ELBW) infants. The VLBW/ELBW infants who were diagnosed with hypothyroidism from September 2018 to December 2019 were enrolled as the case group (n=29). The children with normal thyroid function, matched at a ratio of 1 : 3, were enrolled as the control group (n=87). Clinical features were compared between the two groups. The correlation of thyroid function with gestational age and birth weight and the risk factors for hypothyroidism were analyzed. A total of 162 VLBW/ELBW infants who met the inclusion criteria were enrolled, with 29 infants in the case group (an incidence rate of hypothyroidism of 17.9%). The lower the birth weight, the higher the incidence rate of hypothyroidism (P<0.05). Triiodothyronine (T3) and free T3 were positively correlated with gestational age (P<0.05). T3 and free thyroxine were positively correlated with birth weight (P<0.05). Small for gestational age, multiple birth, maternal age ≥ 35 years, and use of dopamine were independent risk factors for hypothyroidism (P<0.05). In the case group, 16 infants were treated with levothyroxine (5-10 μg/kg daily), and the thyroid function returned to normal after 2 weeks of treatment. There is a high incidence rate of hypothyroidism in VLBW/ELBW infants. Small for gestational age, multiple birth, advanced maternal age, and use of dopamine are risk factors for hypothyroidism. The infants treated with levothyroxine should be followed up regularly to ensure an appropriate dose.
Identifiants
pubmed: 33059803
pii: 10.7499/j.issn.1008-8830.2005085
pmc: PMC7569004
Substances chimiques
Thyroxine
Q51BO43MG4
Types de publication
Journal Article
Langues
chi
Sous-ensembles de citation
IM
Pagination
1073-1078Références
J Pediatr. 2014 Jun;164(6):1296-302
pubmed: 24518164
J Clin Endocrinol Metab. 2013 Nov;98(11):4499-506
pubmed: 23979950
Ann Pediatr Endocrinol Metab. 2019 Mar;24(1):15-21
pubmed: 30943675
Semin Neonatol. 2004 Feb;9(1):3-11
pubmed: 15013471
Pediatrics. 2009 Aug;124(2):e258-68
pubmed: 19581264
Pediatrics. 2014 Apr;133(4):e955-63
pubmed: 24685955
J Clin Endocrinol Metab. 2017 Aug 1;102(8):3050-3055
pubmed: 28637222
Arch Dis Child Educ Pract Ed. 2015 Oct;100(5):260-3
pubmed: 25776656
J Pediatr Endocrinol Metab. 2015 Jan;28(1-2):177-82
pubmed: 25153575
Korean J Pediatr. 2015 Jun;58(6):224-9
pubmed: 26213551
Pediatrics. 2005 Nov;116(5):e613-8
pubmed: 16234230
J Pediatr. 2019 Apr;207:220-225
pubmed: 30579585
Zhongguo Dang Dai Er Ke Za Zhi. 2020 Jan;22(1):37-41
pubmed: 31948522
J Korean Med Sci. 2009 Aug;24(4):627-31
pubmed: 19654943
Clin Biochem. 2014 Jan;47(1-2):16-8
pubmed: 24125878
Data Brief. 2018 Nov 27;21:2510-2514
pubmed: 30560160
Pediatr Neonatol. 2018 Feb;59(1):3-14
pubmed: 28811156
J Clin Endocrinol Metab. 2004 Nov;89(11):5314-20
pubmed: 15531476